D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Imperial Oil
IMO
$46.3B
| $3.89M | ﹤0.01% |
55,290
-37,411
| -40% | -$2.63M |
|
1302
Aclaris Therapeutics
ACRS
$211M
| $3.88M | ﹤0.01% |
3,371,849
+51,643
| +2% | +$59.4K |
|
1303
Dana Inc
DAN
$2.76B
| $3.87M | ﹤0.01% |
366,241
-195,919
| -35% | -$2.07M |
|
1304
Cameco
CCJ
$34B
| $3.85M | ﹤0.01% |
80,643
+56,068
| +228% | +$2.68M |
|
1305
SPDR Euro Stoxx 50 ETF
FEZ
$4.59B
| $3.85M | ﹤0.01% |
72,322
+44,069
| +156% | +$2.35M |
|
1306
Bioventus
BVS
$484M
| $3.84M | ﹤0.01% |
321,630
+124,455
| +63% | +$1.49M |
|
1307
VanEck Morningstar Wide Moat ETF
MOAT
$12.6B
| $3.84M | ﹤0.01% |
39,615
-162,079
| -80% | -$15.7M |
|
1308
Frontier Communications
FYBR
$9.39B
| $3.84M | ﹤0.01% |
+108,100
| New | +$3.84M |
|
1309
Millicom
TIGO
$7.94B
| $3.84M | ﹤0.01% |
141,534
+39,063
| +38% | +$1.06M |
|
1310
COPT Defense Properties
CDP
$3.46B
| $3.84M | ﹤0.01% |
126,463
+42,473
| +51% | +$1.29M |
|
1311
OR Royalties Inc.
OR
$6.76B
| $3.83M | ﹤0.01% |
+206,687
| New | +$3.83M |
|
1312
Avis
CAR
$5.47B
| $3.82M | ﹤0.01% |
43,621
+9,771
| +29% | +$856K |
|
1313
Janux Therapeutics
JANX
$1.45B
| $3.82M | ﹤0.01% |
83,989
-13,834
| -14% | -$628K |
|
1314
Anika Therapeutics
ANIK
$125M
| $3.81M | ﹤0.01% |
154,061
+1,138
| +0.7% | +$28.1K |
|
|
MODV
1315
DELISTED
ModivCare
MODV
| $3.78M | ﹤0.01% |
264,949
-6,824
| -3% | -$97.4K |
|
1316
Cars.com
CARS
$829M
| $3.78M | ﹤0.01% |
225,494
+86,852
| +63% | +$1.46M |
|
1317
Fortune Brands Innovations
FBIN
$7.12B
| $3.78M | ﹤0.01% |
42,168
-295,397
| -88% | -$26.4M |
|
1318
Vanguard Small-Cap Growth ETF
VBK
$20.5B
| $3.77M | ﹤0.01% |
14,087
-23,956
| -63% | -$6.41M |
|
1319
PotlatchDeltic
PCH
$3.2B
| $3.73M | ﹤0.01% |
82,850
+14,220
| +21% | +$641K |
|
1320
Blue Owl Capital
OBDC
$7.23B
| $3.73M | ﹤0.01% |
255,826
+68,819
| +37% | +$1M |
|
1321
LXP Industrial Trust
LXP
$2.72B
| $3.73M | ﹤0.01% |
370,776
-72,553
| -16% | -$729K |
|
1322
ResMed
RMD
$39.6B
| $3.73M | ﹤0.01% |
15,264
+13,064
| +594% | +$3.19M |
|
1323
Minerals Technologies
MTX
$1.99B
| $3.7M | ﹤0.01% |
47,891
-30,959
| -39% | -$2.39M |
|
1324
Triumph Financial, Inc.
TFIN
$1.4B
| $3.69M | ﹤0.01% |
46,358
-446
| -1% | -$35.5K |
|
1325
Hamilton Insurance Group
HG
$2.42B
| $3.69M | ﹤0.01% |
190,590
+147,022
| +337% | +$2.84M |
|